Engineered human liver tissues may be an alternate means of generating hepatitis models Jan. 16, 2014
GlaxoSmithKline presents a novel antibody-drug conjugate for the treatment of multiple myeloma Jan. 13, 2014
OxiGene presents results from a phase I trial evaluating OXi-4503 in patients with AML and MDS Jan. 13, 2014
Preclinical development of AIC-649 as a new strategy for the treatment of chronic viral infections Jan. 10, 2014
RSS